http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4503036-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb2648e65ad8850515bd727a122f1186
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-879
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0275
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
filingDate 1982-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1985-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c80e5b39396ae267ec9f706d30308b49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56db507b31a1e1f49b75d3c40866cf16
publicationDate 1985-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4503036-A
titleOfInvention Process for producing a biochemical vaccine against Salmonella infection
abstract A bacterial vaccine against Salmonella fevers, typhoid and paratyphoid fevers is obtained by fermentation, extraction and purification, vaccinating membrane antigens being extracted by putting the bacterial residue, obtained by centrifuging, in contact with a solvent of the tris (hydroxyalkyl) aminoalkane class, with stirring, at lowered temperature, pH adjusted between 8.4 and 8.6 for a period of at least some 60 hours, then, separated by decanting, followed by purifying the antigens and fractionating by ultrafiltration, and then freeze-drying the vaccinating antigen fraction. Such vaccinating antigen fraction has a molecular weight greater than 50,000, preferably 300,000, and is used to vaccinate humans and animals.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5554372-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5436001-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4981685-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8801873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6605285-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6254874-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5580557-A
priorityDate 1981-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128479187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127897641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420122671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11355505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401012
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129024449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454552299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127922471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID547739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401011

Total number of triples: 42.